United States (Change Country)
1 Product Citation(s)
Tosedostat (CHR2797) Chemical Structure
Tosedostat (CHR2797) is an aminopeptidase inhibitor with IC50 of 100, 150, 220, >1000, >5000, >10000 and >30000 nM for LAP, PuSA, aminopeptidase N, aminopeptidase B, PILSAP, LTA4 hydrolase and MetAP2, respectively.
It has demonstrated anti-tumour activity in a number of models of cancer, both as a single agent and in synergy with cytotoxic agents such as carboplatin and paclitaxel. [1][2]
[1] Cancer Res 2008;68:6669-6679
[2] Clin Cancer Res 2009;15:4978-4985
| Molecular Weight (WM): | 406.47 |
|---|---|
| Formula: | C21H30N2O6 |
| Solubility(R.T.:25°C): | DMSO 51mg/mL |
| Water <1mg/mL | |
| Ethanol 5mg/mL |
A collection of 715 inhibitors
A collection of 271 kinase inhibitors
A collection of 785 FDA approved drugs
A collection of 144 natural products
A collection of 84 chemotherapeutic agents
A collection of 1463 bioactive compounds
A collection of 117 tyrosine kinase inhibitors
Keywords:buy Tosedostat (CHR2797) | Tosedostat (CHR2797) supplier | purchase Tosedostat (CHR2797) | Tosedostat (CHR2797) cost | Tosedostat (CHR2797) manufacturer | order Tosedostat (CHR2797) | Tosedostat (CHR2797) distributor